Stay updated on Pembrolizumab in Esophagogastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Esophagogastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Esophagogastric Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    - Added a government operating status notice and new version (v3.2.0). - Removed a specific resource (Carcinoma of esophagus) and the old version tag (v3.1.0).
    Difference
    4%
    Check dated 2025-10-06T05:19:30.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T03:00:57.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.
    Difference
    0.2%
    Check dated 2025-09-14T19:01:31.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-07T14:59:12.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, while key medical topics such as Esophageal Cancer and pembrolizumab have been removed.
    Difference
    3%
    Check dated 2025-08-31T11:46:07.000Z thumbnail image
  8. Check
    60 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-17T01:54:50.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Esophagogastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Esophagogastric Cancer Clinical Trial page.